Treatment outcome of a combined dose-escalated treatment regime With helical tomotherapy® and active raster-scanning carbon ion boost for adenocarcinomas of the head and neck

Introduction: Data regarding treatment and survival outcome of patients with adenocarcinoma of the head and neck are limited to case reports and case series. As a consequence of lacking evidence, treatment guidelines do not exist. We aimed to analyze the effect of a bimodal irradiation regime with i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Akbaba, Sati (VerfasserIn) , Mock, Andreas (VerfasserIn) , Hörner-Rieber, Juliane (VerfasserIn) , Held, Thomas (VerfasserIn) , Katayama, Sonja (VerfasserIn) , Forster, Tobias (VerfasserIn) , Freudlsperger, Christian (VerfasserIn) , Rieken, Stefan (VerfasserIn) , Herfarth, Klaus (VerfasserIn) , Plinkert, Peter K. (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Adeberg, Sebastian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 13 August 2019
In: Frontiers in oncology
Year: 2019, Jahrgang: 9
ISSN:2234-943X
DOI:10.3389/fonc.2019.00755
Online-Zugang:Verlag, Volltext: https://doi.org/10.3389/fonc.2019.00755
Verlag: https://www.frontiersin.org/articles/10.3389/fonc.2019.00755/full
Volltext
Verfasserangaben:Sati Akbaba, Andreas Mock, Juliane Hoerner-Rieber, Thomas Held, Sonja Katayama, Tobias Forster, Christian Freudlsperger, Stefan Rieken, Klaus Herfarth, Peter Plinkert, Juergen Debus and Sebastian Adeberg

MARC

LEADER 00000caa a2200000 c 4500
001 1678211672
003 DE-627
005 20210816225504.0
007 cr uuu---uuuuu
008 191007s2019 xx |||||o 00| ||eng c
024 7 |a 10.3389/fonc.2019.00755  |2 doi 
035 |a (DE-627)1678211672 
035 |a (DE-599)KXP1678211672 
035 |a (OCoLC)1264101556 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Akbaba, Sati  |d 1987-  |e VerfasserIn  |0 (DE-588)1150864648  |0 (DE-627)1011125226  |0 (DE-576)497297116  |4 aut 
245 1 0 |a Treatment outcome of a combined dose-escalated treatment regime With helical tomotherapy® and active raster-scanning carbon ion boost for adenocarcinomas of the head and neck  |c Sati Akbaba, Andreas Mock, Juliane Hoerner-Rieber, Thomas Held, Sonja Katayama, Tobias Forster, Christian Freudlsperger, Stefan Rieken, Klaus Herfarth, Peter Plinkert, Juergen Debus and Sebastian Adeberg 
264 1 |c 13 August 2019 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.10.2019 
520 |a Introduction: Data regarding treatment and survival outcome of patients with adenocarcinoma of the head and neck are limited to case reports and case series. As a consequence of lacking evidence, treatment guidelines do not exist. We aimed to analyze the effect of a bimodal irradiation regime with intensity modulated radiotherapy (IMRT) and carbon ion boost on local control (LC) and survival in adenocarcinoma patients for a large patient collective. Materials and Methods: Patient records of eighty consecutive patients treated between 2009 and 2018 were analyzed retrospectively and Kaplan-Meier estimates for LC, overall survival (OS) and progression-free survival (PFS) were compared among patients with salivary gland adenocarcinoma (SGAC), salivary duct adenocarcinoma (SDAC) and intestinal-type adenocarcinoma (ITAC) according to the World Health Organization. Prognostic factors were identified using the log-rank test and cox-regression modelling. Toxicity was assessed according to the Common Terminology Criteria for Adverse Events. Results: Median follow-up was 41 months. The 3-year and estimated 5-year Kaplan-Meier rates for all patients were 83% and 75% for LC, 74% and 50% for OS and 60% and 53% for PFS, respectively. While bimodal RT for ITAC resulted in a significantly decreased 3-year LC rate of 50% vs. 93% for each SGAC and SDAC (p<0.01), no statistical significant survival differences could be identified across the three groups regarding OS (p=0.08) and PFS (p=0.063). 3-year OS was 88% for SGAC, 78% for SDAC and 67% for ITAC and 3-year PFS was 72% for SGAC, 53% for SDAC and 44% for ITAC, respectively. Nevertheless, in subgroup analysis, OS for ITAC was significantly worse compared to SGAC (p=0.024). In multivariate analysis, bilateral tumor side (vs. unilateral) solely could be identified as independent negative prognostic factor for LC (p<0.01). Treatment was well tolerated with 21% acute (n=17) and 25% (n=20) late grade ≥3 toxicities. Conclusion: Radiotherapy including active raster-scanning carbon ion boost for relatively radio resistant adenocarcinomas of the head and neck resulted in favorable survival outcome for salivary gland and salivary duct adenocarcinomas with moderate toxicity. However, local control and prognosis for bilateral intestinal-type adenocarcinomas seem to remain low even after dose-escalation. 
650 4 |a Carbon ion radiotherapy 
650 4 |a Intestinal-type adenocarcinoma 
650 4 |a local control 
650 4 |a salivary duct adenocarcinoma 
650 4 |a Salivary gland adenocarcinoma 
650 4 |a side effects 
650 4 |a tomotherapy 
700 1 |a Mock, Andreas  |d 1989-  |e VerfasserIn  |0 (DE-588)1071913905  |0 (DE-627)826601995  |0 (DE-576)433423331  |4 aut 
700 1 |a Hörner-Rieber, Juliane  |d 1985-  |e VerfasserIn  |0 (DE-588)1025307631  |0 (DE-627)722020511  |0 (DE-576)370188039  |4 aut 
700 1 |a Held, Thomas  |d 1990-  |e VerfasserIn  |0 (DE-588)1172053723  |0 (DE-627)104086970X  |0 (DE-576)513977627  |4 aut 
700 1 |a Katayama, Sonja  |e VerfasserIn  |0 (DE-588)1067255028  |0 (DE-627)818554177  |0 (DE-576)426512979  |4 aut 
700 1 |a Forster, Tobias  |d 1986-  |e VerfasserIn  |0 (DE-588)1102961132  |0 (DE-627)860567028  |0 (DE-576)470399430  |4 aut 
700 1 |a Freudlsperger, Christian  |d 1977-  |e VerfasserIn  |0 (DE-588)130275913  |0 (DE-627)589450751  |0 (DE-576)301504105  |4 aut 
700 1 |a Rieken, Stefan  |d 1979-  |e VerfasserIn  |0 (DE-588)135553385  |0 (DE-627)567062570  |0 (DE-576)278641725  |4 aut 
700 1 |a Herfarth, Klaus  |e VerfasserIn  |0 (DE-588)1032757582  |0 (DE-627)739273116  |0 (DE-576)171352289  |4 aut 
700 1 |a Plinkert, Peter K.  |e VerfasserIn  |0 (DE-588)1032658509  |0 (DE-627)739933043  |0 (DE-576)169008908  |4 aut 
700 1 |a Debus, Jürgen  |d 1964-  |e VerfasserIn  |0 (DE-588)1022671421  |0 (DE-627)717025780  |0 (DE-576)365774944  |4 aut 
700 1 |a Adeberg, Sebastian  |d 1984-  |e VerfasserIn  |0 (DE-588)1049743377  |0 (DE-627)782574467  |0 (DE-576)403727774  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in oncology  |d Lausanne : Frontiers Media, 2011  |g 9(2019) Artikel-Nummer 755, 11 Seiten  |h Online-Ressource  |w (DE-627)684965518  |w (DE-600)2649216-7  |w (DE-576)35841184X  |x 2234-943X  |7 nnas  |a Treatment outcome of a combined dose-escalated treatment regime With helical tomotherapy® and active raster-scanning carbon ion boost for adenocarcinomas of the head and neck 
773 1 8 |g volume:9  |g year:2019  |g extent:11  |a Treatment outcome of a combined dose-escalated treatment regime With helical tomotherapy® and active raster-scanning carbon ion boost for adenocarcinomas of the head and neck 
856 4 0 |u https://doi.org/10.3389/fonc.2019.00755  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fonc.2019.00755/full  |x Verlag 
951 |a AR 
992 |a 20191007 
993 |a Article 
994 |a 2019 
998 |g 1049743377  |a Adeberg, Sebastian  |m 1049743377:Adeberg, Sebastian  |d 910000  |d 911400  |d 50000  |e 910000PA1049743377  |e 911400PA1049743377  |e 50000PA1049743377  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 12  |y j 
998 |g 1022671421  |a Debus, Jürgen  |m 1022671421:Debus, Jürgen  |d 910000  |d 911400  |e 910000PD1022671421  |e 911400PD1022671421  |k 0/910000/  |k 1/910000/911400/  |p 11 
998 |g 1032658509  |a Plinkert, Peter K.  |m 1032658509:Plinkert, Peter K.  |d 910000  |d 911000  |e 910000PP1032658509  |e 911000PP1032658509  |k 0/910000/  |k 1/910000/911000/  |p 10 
998 |g 135553385  |a Rieken, Stefan  |m 135553385:Rieken, Stefan  |d 910000  |d 911400  |e 910000PR135553385  |e 911400PR135553385  |k 0/910000/  |k 1/910000/911400/  |p 8 
998 |g 1032757582  |a Herfarth, Klaus  |m 1032757582:Herfarth, Klaus  |d 910000  |d 911400  |e 910000PH1032757582  |e 911400PH1032757582  |k 0/910000/  |k 1/910000/911400/  |p 9 
998 |g 1025307631  |a Hörner-Rieber, Juliane  |m 1025307631:Hörner-Rieber, Juliane  |d 910000  |d 911400  |e 910000PH1025307631  |e 911400PH1025307631  |k 0/910000/  |k 1/910000/911400/  |p 3 
998 |g 130275913  |a Freudlsperger, Christian  |m 130275913:Freudlsperger, Christian  |d 910000  |d 910800  |e 910000PF130275913  |e 910800PF130275913  |k 0/910000/  |k 1/910000/910800/  |p 7 
998 |g 1172053723  |a Held, Thomas  |m 1172053723:Held, Thomas  |d 910000  |d 911400  |e 910000PH1172053723  |e 911400PH1172053723  |k 0/910000/  |k 1/910000/911400/  |p 4 
998 |g 1102961132  |a Forster, Tobias  |m 1102961132:Forster, Tobias  |d 910000  |d 911400  |e 910000PF1102961132  |e 911400PF1102961132  |k 0/910000/  |k 1/910000/911400/  |p 6 
998 |g 1071913905  |a Mock, Andreas  |m 1071913905:Mock, Andreas  |d 910000  |d 910100  |e 910000PM1071913905  |e 910100PM1071913905  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1067255028  |a Katayama, Sonja  |m 1067255028:Katayama, Sonja  |d 910000  |d 911400  |e 910000PK1067255028  |e 911400PK1067255028  |k 0/910000/  |k 1/910000/911400/  |p 5 
998 |g 1150864648  |a Akbaba, Sati  |m 1150864648:Akbaba, Sati  |d 910000  |d 911400  |e 910000PA1150864648  |e 911400PA1150864648  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1678211672  |e 3519995182 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1678211672","note":["Gesehen am 07.10.2019"],"name":{"displayForm":["Sati Akbaba, Andreas Mock, Juliane Hoerner-Rieber, Thomas Held, Sonja Katayama, Tobias Forster, Christian Freudlsperger, Stefan Rieken, Klaus Herfarth, Peter Plinkert, Juergen Debus and Sebastian Adeberg"]},"relHost":[{"disp":"Treatment outcome of a combined dose-escalated treatment regime With helical tomotherapy® and active raster-scanning carbon ion boost for adenocarcinomas of the head and neckFrontiers in oncology","pubHistory":["2011 -"],"note":["Gesehen am 07.11.13"],"recId":"684965518","origin":[{"dateIssuedKey":"2011","publisher":"Frontiers Media","publisherPlace":"Lausanne","dateIssuedDisp":"2011-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"eki":["684965518"],"zdb":["2649216-7"],"issn":["2234-943X"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Frontiers in oncology","title":"Frontiers in oncology"}],"part":{"text":"9(2019) Artikel-Nummer 755, 11 Seiten","volume":"9","extent":"11","year":"2019"}}],"person":[{"family":"Akbaba","display":"Akbaba, Sati","given":"Sati","role":"aut"},{"role":"aut","given":"Andreas","family":"Mock","display":"Mock, Andreas"},{"role":"aut","family":"Hörner-Rieber","display":"Hörner-Rieber, Juliane","given":"Juliane"},{"role":"aut","family":"Held","display":"Held, Thomas","given":"Thomas"},{"family":"Katayama","display":"Katayama, Sonja","given":"Sonja","role":"aut"},{"role":"aut","given":"Tobias","display":"Forster, Tobias","family":"Forster"},{"given":"Christian","display":"Freudlsperger, Christian","family":"Freudlsperger","role":"aut"},{"role":"aut","given":"Stefan","family":"Rieken","display":"Rieken, Stefan"},{"display":"Herfarth, Klaus","family":"Herfarth","given":"Klaus","role":"aut"},{"given":"Peter K.","family":"Plinkert","display":"Plinkert, Peter K.","role":"aut"},{"role":"aut","given":"Jürgen","display":"Debus, Jürgen","family":"Debus"},{"role":"aut","family":"Adeberg","display":"Adeberg, Sebastian","given":"Sebastian"}],"title":[{"title_sort":"Treatment outcome of a combined dose-escalated treatment regime With helical tomotherapy® and active raster-scanning carbon ion boost for adenocarcinomas of the head and neck","title":"Treatment outcome of a combined dose-escalated treatment regime With helical tomotherapy® and active raster-scanning carbon ion boost for adenocarcinomas of the head and neck"}],"physDesc":[{"extent":"11 S."}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"13 August 2019"}],"id":{"doi":["10.3389/fonc.2019.00755"],"eki":["1678211672"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"]} 
SRT |a AKBABASATITREATMENTO1320